JESDUVROQ

Glaxo Group Limited

Application Filed: 2020-06-17
Trademark Application Details
Trademark Logo JESDUVROQ

Mark For: JESDUVROQ® trademark registration is intended to cover the categories of vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders. [all]

Status

2021-05-04 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number90006591
Registration Number6368192
Mark Literal ElementsJESDUVROQ
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2021-02-11
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUNo
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameChristopher M. Hanes
Attorney Docket Number83094433

Timeline

2020-02-11Trademark Registered
2020-06-17Application Filed
2020-06-20Location: NEW APPLICATION PROCESSING
2020-06-20Status: Live/Pending
2020-06-20Transaction Date
2021-02-11Location: PUBLICATION AND ISSUE SECTION
2021-03-16Published
2021-03-16Status: Application has been published for opposition. The opposition period begins on the date of publication.
2021-06-01Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Glaxo Group Limited
Address980 Great West Road Brentford, Middlesex ENGLAND TW89GS
Legal Entity TypePrivate Company Limited By Shares (prc)
Legal Entity StateENGLAND

Attorney of Record

CHRISTOPHER M. HANES
GSK
5 MOORE DRIVE
LBP 5.5A
RESEARCH TRIANGLE PARK, NC 27709

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
GS0051Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Filing History

DescriptionDateProceeding Number
ASSIGNED TO EXAMINER2021-03-2976136
PUBLISHED FOR OPPOSITION2021-03-16
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-03-16
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-02-24
APPROVED FOR PUB - PRINCIPAL REGISTER2021-02-10
TEAS/EMAIL CORRESPONDENCE ENTERED2021-02-0974221
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-02-0974221
ASSIGNED TO LIE2021-02-0974221
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED2020-11-04
SUSPENSION LETTER WRITTEN2020-09-2081856
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2020-09-206332
LETTER OF SUSPENSION E-MAILED2020-09-206332
ASSIGNED TO EXAMINER2020-09-2081856
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-07-15
NEW APPLICATION ENTERED IN TRAM2020-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed